These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 6884415)

  • 1. A phenylbutazone dose-finding study in rheumatoid arthritis.
    Bird HA; Leatham PA; Lowe JR; Downie WW; Fowler PD; Wright V
    Eur J Clin Pharmacol; 1983; 24(6):773-6. PubMed ID: 6884415
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phenylbutazone: plasma concentrations and effectiveness in patients with rheumatoid arthritis.
    Orme ML
    J Int Med Res; 1977; 5 Suppl 2():40-7. PubMed ID: 913873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma concentration of phenylbutazone and its therapeutic effect-studies in patients with rheumatoid arthritis.
    Orme M; Holt PJ; Hughes GR; Bulpitt CJ; Draffan GH; Thorgeirsson SS; Williams F; Davies DS
    Br J Clin Pharmacol; 1976 Feb; 3(1):185-91. PubMed ID: 788739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A chronic dose-ranging study of the pharmacokinetics of phenylbutazone in rheumatoid arthritic patients.
    Higham C; Aarons L; Holt PJ; Lynch M; Rowland M
    Br J Clin Pharmacol; 1981 Aug; 12(2):123-9. PubMed ID: 7306426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phenylbutazone dose response data in patients with rheumatoid artritis.
    Dick WC; Brooks PM; Buchanan WW; Fowler PD
    J Int Med Res; 1977; 5 Suppl 2():48-51. PubMed ID: 913874
    [No Abstract]   [Full Text] [Related]  

  • 6. Phenylbutazone: a clinico-pharmacological study in rheumatoid arthritis.
    Brooks PM; Walker JJ; Dick WC
    Br J Clin Pharmacol; 1975 Oct; 2(5):437-42. PubMed ID: 786356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Comparison of bumadizone-, phenylbutazone- and oxyphenbutazone-plasma levels after a single oral dose of phenylbutazone and of bumadizone, respectively (author's transl)].
    Spahn H; Mutschler E; Geissler HE; Faust-Tinnefeldt G
    Arzneimittelforschung; 1981; 31(3):499-503. PubMed ID: 6894380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A double-blind cross-over study of ketoprofen and phenylbutazone in rheumatoid arthritis.
    Peltola P
    Scand J Rheumatol Suppl; 1976; 1976(0):111-3. PubMed ID: 790546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new pyrazolidine derivative - benetazone spofa - in short- and medium-term treatment of rheumatoid arthritis. (Double-blind comparative study with phenylbutazone).
    Pavelka K; Vojtisek O; Bremová A; Kauková D; Hándlová D
    Int J Clin Pharmacol Biopharm; 1976 Jul; 14(1):20-8. PubMed ID: 61951
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparative clinical study of a new antirheumatic agent, tolfenamic acid (Clotam), and phenylbutazone in rheumatoid arthritis.
    Nyfos L
    Scand J Rheumatol Suppl; 1979; (24):5-7. PubMed ID: 373085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adverse reactions with long-term use of phenylbutazone and oxyphenbutazone.
    Sperling IL
    Lancet; 1969 Sep; 2(7619):535-7. PubMed ID: 4184850
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical evaluation of ketoprofen (Orudis) in rheumatoid arthritis. Results of a multi-centre, double-blind, cross-over trial against phenylbutazone.
    Sydnes O; Brath HK; Haerum LB; Straume S
    Scand J Rheumatol Suppl; 1976; 1976(0):119-22. PubMed ID: 790547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparative, double-blind study on tolfenamic acid in the treatment of rheumatoid arthritis.
    Rejholec V; Vapaatalo H; Tokola O; Gothoni G
    Scand J Rheumatol Suppl; 1979; (24):13-6. PubMed ID: 373084
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A double-blind comparison of phenylbutazone and suxibuzone, a prodrug of phenylbutazone, in rheumatoid arthritis.
    Mizushima Y; Shiokawa Y; Honma M; Kageyama T
    Int J Tissue React; 1983; 5(1):35-9. PubMed ID: 6345427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The influence of allopurinol and size of dose on the metabolism of phenylbutazone in patients with gout.
    Horwitz D; Thorgeirsson SS; Mitchell JR
    Eur J Clin Pharmacol; 1977 Oct; 12(2):133-6. PubMed ID: 923626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms of inhibition of tolbutamide metabolism: phenylbutazone, oxyphenbutazone, sulfaphenazole.
    Pond SM; Birkett DJ; Wade DN
    Clin Pharmacol Ther; 1977 Nov; 22(5 Pt 1):573-9. PubMed ID: 913025
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A double blind trial to assess the value of alclofenac compared with phenylbutazone in the management of rheumatoid arthritis.
    Chamberlain MA; Wright V
    Ann Rheum Dis; 1975 Apr; 34(2):186-9. PubMed ID: 237493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rheumatoid arthritis: comparison of treatment with monophenylbutazone and phenylbutazone.
    Woodbury JF; Turner WA; Tiongson R
    Can Med Assoc J; 1969 Dec; 101(13):69-71. PubMed ID: 4903691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Double-blind comparison of ibuprofen and phenylbutazone in a short-term treatment of rheumatoid arthritis.
    Pavelka K; Susta A; Vojtísek O; Brémová A; Kanková D; Hándlová D; Malecek J
    Arzneimittelforschung; 1973 Jun; 23(6):842-6. PubMed ID: 4579953
    [No Abstract]   [Full Text] [Related]  

  • 20. [Clinical evaluation of a new phenylbutazone-based compound].
    Chériè Lignière G; Guastalla A
    Reumatismo; 1968; 20(4):279-83. PubMed ID: 5738056
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.